,      

  
Health Watch USA Logo
  
Utility of Bacteriophages to Combat Drug Resistant Bacteria
Deborah Birx - Feb. 19, 2025
   
   

 
   

Utility of Bacteriophages to Combat Drug Resistant Bacteria
  
Ambassador Deborah Birx, MD addresses the topic of bacteriophages, which are viruses capable of eliminating antibiotic-resistant bacteria. The existence of phages has been known for approximately 100 years. This therapy has been utilized in Eastern Europe for 20 to 30 years and represents established technology. Bacteriophages exhibit high specificity for their target bacteria, and unlike antibiotics, they do not disrupt the patient's microbiome. The discussion includes details on three Phase II clinical trials and outlines potential parameters for an upcoming Phase III clinical trial. The ongoing research focuses on infections caused by Pseudomonas and MRSA. In the future, phage therapy could potentially serve as either a standalone treatment or a complementary treatment alongside antibiotics for severe and resistant bacterial infections. This presentation was part of the Health Watch USAsm meeting held on February 19, 2024. You Tube Video: https://youtu.be/_E02UFdca6g   
  

 
All information contained on this website is the express opinion /span> strong>strong>
of the presentor and not necessarily that of
Health Watch USA Inc. a Kentucky Non-Profit Organization


The Video Above is a Health Watch USAsm Video. 
Health Watch USA is a non-profit 501-C3 Organization based in Kentucky